We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
+12.24%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$7.48B
AUM Growth
+$822M
Cap. Flow
+$338M
Cap. Flow %
4.52%
Top 10 Hldgs %
42.69%
Holding
349
New
98
Increased
52
Reduced
49
Closed
146

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$251M
2
RTX icon
RTX Corp
RTX
+$211M
3
TECH icon
Bio-Techne
TECH
+$161M
4
ASML icon
ASML
ASML
+$150M
5
SHW icon
Sherwin-Williams
SHW
+$135M

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Consumer Discretionary 17.62%
3 Healthcare 16.47%
4 Financials 11.15%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
26
Monster Beverage
MNST
$95.1B
$90.3M 1.21%
+1,341,965
New +$83.8M
TEVA icon
27
Teva Pharmaceuticals
TEVA
$40.4B
$86.9M 1.16%
4,300,520
-77,170
-2% -$1.36M
SCHW
28
Charles Schwab
SCHW
$182B
$83.1M 1.11%
+870,072
New +$82.6M
CVNA icon
29
Carvana
CVNA
$47.5B
$82.1M 1.1%
+1,087,760
New +$77.8M
Z icon
30
Zillow
Z
$7.78B
$79.5M 1.06%
+1,031,622
New +$84.3M
GFL icon
31
GFL Environmental
GFL
$14.5B
$75.2M 1.01%
1,586,998
-1,213,458
-43% -$58.8M
ACHC icon
32
Acadia Healthcare
ACHC
$2.52B
$74.4M 1%
3,006,505
+453,268
+18% +$10.1M
CART icon
33
Maplebear
CART
$10.7B
$73.1M 0.98%
1,989,924
-179,040
-8% -$8.24M
CPNG icon
34
Coupang
CPNG
$27.2B
$66.8M 0.89%
2,073,752
-29,025
-1% -$877K
SNOW icon
35
Snowflake
SNOW
$98.1B
$63.6M 0.85%
281,903
-258,176
-48% -$55.4M
WVE icon
36
Wave Life Sciences
WVE
$1.12B
$61.4M 0.82%
8,391,856
+130,173
+2% +$1.05M
MIR icon
37
Mirion Technologies
MIR
$3.56B
$60.2M 0.8%
2,588,579
-2,719,459
-51% -$58.8M
CELH icon
38
Celsius Holdings
CELH
$7.38B
$59.3M 0.79%
+1,031,603
New +$53.9M
RBLX icon
39
Roblox
RBLX
$35.9B
$57M 0.76%
411,547
+16,672
+4% +$2.07M
CCL icon
40
Carnival Corporation Ltd
CCL
$38.1B
$55.3M 0.74%
1,912,372
-3,464,498
-64% -$105M
DDOG icon
41
Datadog
DDOG
$94B
$48.6M 0.65%
341,412
-174,667
-34% -$24.1M
VRDN icon
42
Viridian Therapeutics
VRDN
$2.2B
$47.8M 0.64%
2,212,701
-44,309
-2% -$799K
PCVX icon
43
Vaxcyte
PCVX
$7.65B
$46.5M 0.62%
1,289,567
-21,038
-2% -$697K
NAMS icon
44
NewAmsterdam Pharma
NAMS
$3.26B
$42.8M 0.57%
1,504,747
-27,127
-2% -$650K
MDB icon
45
MongoDB
MDB
$25.8B
$42.5M 0.57%
+136,932
New +$35.2M
MELI icon
46
Mercado Libre
MELI
$94.5B
$40.2M 0.54%
17,197
-295
-2% -$708K
CDTX
47
DELISTED
Cidara Therapeutics
CDTX
$40M 0.53%
+417,550
New +$26.6M
PRMB
48
Primo Brands
PRMB
$8.35B
$37.3M 0.5%
1,689,881
-741,988
-31% -$19.2M
FLUT icon
49
Flutter Entertainment
FLUT
$18.7B
$34M 0.45%
133,952
-162,060
-55% -$47.4M
RCKT icon
50
Rocket Pharmaceuticals
RCKT
$343M
$27.6M 0.37%
8,468,344
+104,531
+1% +$329K

Similar funds

Maverick Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Maverick Capital held 349 positions worth $7.48B, up 12% from $6.66B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Maverick Capital deployed $338M of net new capital in Q3 2025, opening 98 new positions and adding to 52 existing holdings. Its largest new stake was Union Pacific: 1,115,610 shares worth $264M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was TSMC, an estimated $181M trimmed.

  • Maverick Capital's largest Q3 2025 buy was Union Pacific: 1,115,610 shares worth $264M.
  • Maverick Capital added most to Sherwin-Williams in Q3 2025, an estimated $135M increase.
  • Maverick Capital's biggest Q3 2025 reduction was TSMC, cutting an estimated $181M.
  • Maverick Capital fully exited Micron Technology in Q3 2025, selling an estimated $135M.
  • Maverick Capital's ten largest holdings make up 43% of its $7.48B portfolio in Q3 2025.
  • Maverick Capital opened 98 new positions and closed 146 in Q3 2025.
  • Maverick Capital's portfolio value rose 12% quarter-over-quarter to $7.48B.

Based on Maverick Capital's 13F filing for Q3 2025, filed 14 Nov 2025.